| COLLPLANT BIOTECHNOLOGIES |
| Israel |
| Gesundheit |
| IL0004960188 / A1CY27 |
| CPT (Frankfurt) / CLGN (NASDAQ) |
| FRA:CPT, ETR:CPT, CPT:GR, NASDAQ:CLGN |
| - |
| https://collplant.com/ |
|
CollPlant Biotechnologies Ltd. is a pioneering biomedical company that specializes in regenerative medicine and tissue engineering. At the heart of its offerings is the development of innovative human tissue products using plant-based recombinant col..
>Volltext.. |
| 4.43 Mio. EUR |
| 1.77 Mio. EUR |
| 2.03 Mio. EUR |
| -9.05 Mio. EUR |
| -9.84 Mio. EUR |
| -0.8 EUR |
| 2.44 Mio. EUR |
| 5.1 Mio. EUR |
| -8.56 Mio. EUR |
| 2.23 |
| 360.39% |
| 30.83% |
| - |
| - |
| - |
| - |
| COLLPLANT |
| 08.04.26 |
|